Human endogenous retroviruses in viral disease and therapy

7Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

As retained sequences of ancient retroviruses, human endogenous retroviruses (HERVs) are widespread in the human genome. Although most HERVs have been inert throughout evolution, several HERVs are still functional and involved in various diseases, such as autoimmune diseases, cancer, neurological diseases and viral infection. Hence, certain types of therapies targeting HERVs or utilizing HERV tools have been developed. Here, we summarize recent findings on the role of HERVs in viral infection, including HERV dysregulation in different kinds of viral infections and the potential mechanisms of HERV-mediated antiviral immunity. In addition, we provide an overview of HERV-related therapies that directly target HERVs or are indirectly based on HERVs to improve the efficacy of vaccines and drugs.

Cite

CITATION STYLE

APA

Li, Y., Fan, T., & Cui, J. (2022, March 1). Human endogenous retroviruses in viral disease and therapy. Clinical and Translational Discovery. Blackwell Publishing. https://doi.org/10.1002/ctd2.38

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free